Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetic nephropathy
diabetic nephropathy
Eyeing second Japanese approval, Daiichi and Exelixis announce positive pivotal for kidney drug
Endpoints
Fri, 11/8/19 - 10:40 am
Daiichi Sankyo
Exelixis
clinical trials
diabetic nephropathy
Minnebro
Ironwood pushing through mid-stage trials with nephropathy drug
BioPharma Dive
Tue, 12/5/17 - 09:35 am
Ironwood Pharmaceuticals
clinical trials
diabetic nephropathy
IW-1973
NephroGenex (NRX) Stock Skyrockets On Positive Data From Cardiac Safety Study Of Pyridorin
Bidness Etc.
Fri, 01/2/15 - 07:38 pm
NephroGenex
Pyridorin
diabetic nephropathy
Concert Pharmaceuticals' Shares Slip Despite Favorable FDA Meeting
Yahoo/Zacks.com
Wed, 07/9/14 - 11:50 am
Concert Pharmaceuticals
FDA
CTP-499
diabetic nephropathy
Neurocrine And ChemoCentryx: Phase II Data Disappoints
Seeking Alpha
Wed, 09/11/13 - 11:25 am
Neurocrine
ChemoCentryx
CCX140
NBI-98854
tardive dyskinesia
diabetic nephropathy
ChemoCentryx Falls on Weak Diabetic Nephropathy Drug Data
TheStreet.com
Tue, 09/10/13 - 11:37 am
ChemoCentryx
diabetic nephropathy
CCX140